Mercer Global Advisors Inc. ADV Has $432,000 Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Posted by Defense World Staff on May 23rd, 2023

Mercer Global Advisors Inc. ADV lessened its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 7.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 13,564 shares of the medical instruments supplier’s stock after selling 1,158 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in DENTSPLY SIRONA were worth $432,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in DENTSPLY SIRONA by 1.2% during the 3rd quarter. Vanguard Group Inc. now owns 24,732,513 shares of the medical instruments supplier’s stock worth $701,167,000 after acquiring an additional 297,487 shares during the period. Artisan Partners Limited Partnership grew its holdings in DENTSPLY SIRONA by 3.7% during the 3rd quarter. Artisan Partners Limited Partnership now owns 13,229,926 shares of the medical instruments supplier’s stock worth $375,068,000 after acquiring an additional 471,200 shares during the period. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 0.7% during the 4th quarter. Nuance Investments LLC now owns 12,642,319 shares of the medical instruments supplier’s stock worth $402,531,000 after acquiring an additional 92,591 shares during the period. Cooke & Bieler LP grew its holdings in DENTSPLY SIRONA by 27.1% during the 4th quarter. Cooke & Bieler LP now owns 5,866,388 shares of the medical instruments supplier’s stock worth $186,786,000 after acquiring an additional 1,249,656 shares during the period. Finally, Wellington Management Group LLP grew its holdings in DENTSPLY SIRONA by 83.1% during the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after acquiring an additional 2,497,773 shares during the period. Institutional investors and hedge funds own 98.52% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on XRAY shares. Stifel Nicolaus lifted their price target on shares of DENTSPLY SIRONA from $37.00 to $41.00 in a research report on Thursday, May 4th. The Goldman Sachs Group lifted their price target on shares of DENTSPLY SIRONA from $34.00 to $39.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 1st. Piper Sandler lifted their price target on shares of DENTSPLY SIRONA from $29.00 to $35.00 and gave the stock a “neutral” rating in a research report on Monday, February 6th. UBS Group lifted their price target on shares of DENTSPLY SIRONA from $43.00 to $46.00 in a research report on Friday, May 5th. Finally, Robert W. Baird lifted their price target on shares of DENTSPLY SIRONA from $36.00 to $46.00 in a research report on Thursday, May 4th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $42.13.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, SVP Cord Friedrich Staehler sold 4,000 shares of DENTSPLY SIRONA stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total value of $157,320.00. Following the sale, the senior vice president now directly owns 97,693 shares in the company, valued at approximately $3,842,265.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other DENTSPLY SIRONA news, SVP Cord Friedrich Staehler sold 4,000 shares of DENTSPLY SIRONA stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total value of $157,320.00. Following the sale, the senior vice president now directly owns 97,693 shares in the company, valued at approximately $3,842,265.69. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Eric Brandt sold 6,200 shares of DENTSPLY SIRONA stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total transaction of $261,454.00. Following the completion of the sale, the director now owns 44,902 shares in the company, valued at $1,893,517.34. The disclosure for this sale can be found here. Company insiders own 0.76% of the company’s stock.

DENTSPLY SIRONA Stock Down 1.9 %

XRAY opened at $39.41 on Tuesday. DENTSPLY SIRONA Inc. has a 12 month low of $26.48 and a 12 month high of $43.24. The firm’s fifty day simple moving average is $39.80 and its 200 day simple moving average is $35.94. The company has a quick ratio of 0.93, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its quarterly earnings data on Wednesday, May 3rd. The medical instruments supplier reported $0.39 EPS for the quarter, beating the consensus estimate of $0.34 by $0.05. The business had revenue of $978.00 million for the quarter, compared to analysts’ expectations of $938.16 million. DENTSPLY SIRONA had a negative net margin of 26.41% and a positive return on equity of 8.65%. The firm’s revenue was up .9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.52 EPS. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 1.91 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 14th. Shareholders of record on Friday, March 31st were paid a $0.125 dividend. The ex-dividend date was Thursday, March 30th. This represents a $0.50 annualized dividend and a yield of 1.27%.

DENTSPLY SIRONA Profile

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.